The year 2020 has been one chock-full of ups and downs. While many companies spiraled, some obvious contenders grew to post strong market capitalization during the...
(Bloomberg) — JPMorgan Asset Management now has more than $400 million in its Thematics – Genetic Therapies fund launched in October, just before the world’s need for...
